Literature DB >> 18843931

[Global alliance against chronic respiratory diseases].

J Bousquet1, R Dahl, N Khaltaev.   

Abstract

Hundreds of millions of people of all ages suffer from chronic respiratory diseases which include asthma and respiratory allergies, chronic obstructive pulmonary disease, occupational lung diseases and pulmonary hypertension. More than 500 million patients live in developing countries or in deprived populations. Chronic respiratory diseases are increasing in prevalence. Although the cost of inaction is clear and unacceptable, chronic respiratory diseases and their risk factors receive insufficient attention from the healthcare community, government officials, media, patients and families. The Fifty-Third World Health Assembly recognised the enormous human suffering caused by chronic diseases and requested the World Health Organization (WHO) Director General to give priority to the prevention and control of chronic diseases, with special emphasis on developing countries. This led to the formation of the WHO Global Alliance against Chronic Respiratory Diseases (GARD). GARD is a voluntary alliance of organisations, institutions and agencies working towards a common vision to improve global lung health according to local needs. GARD is developed in a stepwise approach using the following three planning steps: estimate population need and advocate action; formulate and adopt policy; and identify policy implementation steps.

Entities:  

Mesh:

Year:  2008        PMID: 18843931

Source DB:  PubMed          Journal:  Pneumonol Alergol Pol        ISSN: 0867-7077


  1 in total

1.  The nationwide program of allergic disease prevention as an implementation of GARD guidelines in Poland.

Authors:  Filip Raciborski; Bolesław Samoliński; Edyta Krzych-Fałta; Aleksandra Grąbczewska; Filip Furman; Michał Bieszczad; Paweł Morkisz; Patrycja Witkowska; Jean Bousquet; Mariusz Gujski
Journal:  J Thorac Dis       Date:  2018-09       Impact factor: 2.895

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.